Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 36 - Brandon Rice and IND Submission with AI

34:47
 
Share
 

Manage episode 506935822 series 3380376
Content provided by Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

My guest in this episode is Brandon Rice.

Brandon is the CEO and co-founder at Weave Bio, a software company focused on automating regulatory submissions in the pharmaceutical industry using AI where he oversees product development, specifically leading the creation of AutoIND, their AI-powered platform for IND preparation.

In this conversation, Brandon discusses his journey to co-founding Weave Bio. He highlights the challenges of regulatory compliance, the potential of AI to streamline processes, and the importance of human oversight in AI-generated content. The discussion also touches on the cultural differences in AI adoption among pharmaceutical companies, global regulatory trends, and the need for open-mindedness towards new technologies.

I thoroughly enjoyed my chat with Brandon and learned a lot about the current AI in pharma landscape. I hope you do too.

Here's Brandon Rice.

  continue reading

37 episodes

Artwork
iconShare
 
Manage episode 506935822 series 3380376
Content provided by Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Samir Gondalia, ISPE Boston, Samir Gondalia, and ISPE Boston or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

My guest in this episode is Brandon Rice.

Brandon is the CEO and co-founder at Weave Bio, a software company focused on automating regulatory submissions in the pharmaceutical industry using AI where he oversees product development, specifically leading the creation of AutoIND, their AI-powered platform for IND preparation.

In this conversation, Brandon discusses his journey to co-founding Weave Bio. He highlights the challenges of regulatory compliance, the potential of AI to streamline processes, and the importance of human oversight in AI-generated content. The discussion also touches on the cultural differences in AI adoption among pharmaceutical companies, global regulatory trends, and the need for open-mindedness towards new technologies.

I thoroughly enjoyed my chat with Brandon and learned a lot about the current AI in pharma landscape. I hope you do too.

Here's Brandon Rice.

  continue reading

37 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play